ARCHIVE OF OLDER REPORTS AND DEVELOPMENTS

APRIL 1996 to Fall 1998

 
  • Crixivan Twice a day studies discontinued:
    Indinavir BID: Additional Applications - NNRTIs, Double Protease; and, a Brief Discussion of Salvage Therapy Approaches & Preventing Failure
    Important updated PK data on Amprenavir, Indinavir, and Efavirenz.
  • NNRTI update: Reports on Efavirenz (EFV); NNRTI Resistance; and Nevirapine (NVP) (04/12/98)
  • Efavirenz (EFV) Reports  includes PK effect of EFV on 141W94; 60 week data on EFV + Indinavir; 24 week data on EFV + AZT/3TC; and EFV CSF Levels in Monkeys (04/12/98)
  • 1592U89 --A New Antiviral For HIV in Development (4/22/96) Glaxo Wellcome's nucleoside reverse transcriptase inhibitor in early studies.
    pdf
You can download the above  files to your computer with Adobe Acrobat Reader (TM) format for easy printing by clicking on pdf .
You can download Adobe Acrobat Reader software for free by clicking on the icon below.

getacro.gif (712 bytes)